Houston Methodist Apr 17 2026 Infections from antibiotic-resistant bacteria are difficult to treat and are responsible for over 2.8 million infections and more than 35,000 deaths in the U.S. each year. A new study in Nature Communications reports that a drug used to lower blood pressure could also be the basis of a promising new treatment for methicillin-resistant Staphylococcus aureus (MRSA). "MRSA commonly causes infections in both hospitals and the community. It infects people in different

Tag-uri: Medicamente